Skip to content
healthcare.dev

Tekturna

NDC 70839-300, aliskiren hemifumarate, tablet, film coated, from LXO US Inc..

Product NDC
70839-300
Status
Listed
Labeler
LXO US Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021985
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70839-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALISKIREN HEMIFUMARATE300 mg/1

Pharmacologic classes

Renin Inhibitor [EPC]; Renin Inhibitors [MoA]

Package NDCNDC-11Package
70839-300-307083903003030 TABLET, FILM COATED in 1 BOTTLE (70839-300-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3dd61fa5-1620-4ebf-bbdb-ede29b92fce2
  • NADAC price for package 70839030030

    GET /v1/drugs/nadac/70839030030

Use it

Look up 70839-300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70839-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70839-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.